<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Salontaji K</submitter><funding>Economic and Social Research Council</funding><funding>NICHD NIH HHS</funding><funding>European Research Council</funding><funding>Medical Research Council</funding><funding>NIMH NIH HHS</funding><funding>ZonMw</funding><funding>Wellcome Trust</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>2911-2918</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7616513</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(9)</volume><pubmed_abstract>Epigenetic age acceleration (EAA), defined as the difference between chronological age and epigenetically predicted age, was calculated from multiple gestational epigenetic clocks (Bohlin, EPIC overlap, and Knight) using DNA methylation levels from cord blood in three large population-based birth cohorts: the Generation R Study (The Netherlands), the Avon Longitudinal Study of Parents and Children (United Kingdom), and the Norwegian Mother, Father and Child Cohort Study (Norway). We hypothesized that a lower EAA associates prospectively with increased ADHD symptoms. We tested our hypotheses in these three cohorts and meta-analyzed the results (n = 3383). We replicated previous research on the association between gestational age (GA) and ADHD. Both clinically measured gestational age as wel</pubmed_abstract><journal>Molecular psychiatry</journal><pubmed_title>Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study.</pubmed_title><pmcid>PMC7616513</pmcid><funding_grant_id>EP/Y015037/1</funding_grant_id><funding_grant_id>R01 HD068437</funding_grant_id><funding_grant_id>ES/K000357/1</funding_grant_id><funding_grant_id>G9815508</funding_grant_id><funding_grant_id>529051022</funding_grant_id><funding_grant_id>217065/Z/19/Z</funding_grant_id><funding_grant_id>R01 MH113930</funding_grant_id><funding_grant_id>101039672</funding_grant_id><funding_grant_id>MC_PC_15018</funding_grant_id><funding_grant_id>MC_PC_19009</funding_grant_id><pubmed_authors>Sanders F</pubmed_authors><pubmed_authors>Felix JF</pubmed_authors><pubmed_authors>Walton E</pubmed_authors><pubmed_authors>Cecil CAM</pubmed_authors><pubmed_authors>Salontaji K</pubmed_authors><pubmed_authors>Page CM</pubmed_authors><pubmed_authors>Bohlin J</pubmed_authors><pubmed_authors>Bekkhus M</pubmed_authors><pubmed_authors>Haftorn KL</pubmed_authors><pubmed_authors>Tiemeier H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study.</name><description>Epigenetic age acceleration (EAA), defined as the difference between chronological age and epigenetically predicted age, was calculated from multiple gestational epigenetic clocks (Bohlin, EPIC overlap, and Knight) using DNA methylation levels from cord blood in three large population-based birth cohorts: the Generation R Study (The Netherlands), the Avon Longitudinal Study of Parents and Children (United Kingdom), and the Norwegian Mother, Father and Child Cohort Study (Norway). We hypothesized that a lower EAA associates prospectively with increased ADHD symptoms. We tested our hypotheses in these three cohorts and meta-analyzed the results (n = 3383). We replicated previous research on the association between gestational age (GA) and ADHD. Both clinically measured gestational age as wel</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-22T16:59:20.024Z</modification><creation>2025-04-06T01:55:22.516Z</creation></dates><accession>S-EPMC7616513</accession><cross_references><pubmed>38561466</pubmed><doi>10.1038/s41380-024-02544-2</doi></cross_references></HashMap>